Kalaris Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.04

-0.18 (-3.45%)

As of May 16, 2:10 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +354.2% upside

Low Target $19.41

Average Target $22.89

High Target $38.59

Current Price $5.04

Current
$5.04

Target
$22.89

$19.41 $22.89 avg $38.59

Scenario Analysis

Bear Case

$19.41

285.1%

Low target

Base Case

$22.89

+354.2%

Avg target

Bull Case

$38.59

+665.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$11.88

-57.6% from high

52-Week Low

$2.14

+135.5% from low

Target vs 52W High

$22.89

+92.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%